This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Jan;75(1):136.

doi: 10.1016/j.lungcan.2011.11.002. Epub 2011 Nov 29.

Does chemotherapy have a role after erlotinib treatment in NSCLC?

Marta P Trojniak, Antonio Jirillo

PMID: 22129858
DOI: 10.1016/j.lungcan.2011.11.002

Comment

Does chemotherapy have a role after erlotinib treatment in NSCLC?

Marta P Trojniak et al. Lung Cancer. 2012 Jan.

. 2012 Jan;75(1):136.

doi: 10.1016/j.lungcan.2011.11.002. Epub 2011 Nov 29.

Authors

Marta P Trojniak, Antonio Jirillo

PMID: 22129858
DOI: 10.1016/j.lungcan.2011.11.002

No abstract available

PubMed Disclaimer

Comment on

Multicenter observational study of erlotinib therapy (OBSTAR) for non small-cell lung cancer: a GFPC study.
Vergnenègre A, Monnet I, Chouaïd C, Hureaux J, Mazières J, Quéré G, Lombard JN, Cumin I, Abdiche S, Ejnaini CN, Bonnabau H, Decroisette Ch; GFPC team. Vergnenègre A, et al. Lung Cancer. 2011 Nov;74(2):264-7. doi: 10.1016/j.lungcan.2011.03.007. Epub 2011 May 14. Lung Cancer. 2011. PMID: 21571389

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information